Stock ACXP ACURX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Acurx Pharmaceuticals, Inc.

Equities

ACXP

US00510M1045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
2.23 USD -0.89% Intraday chart for Acurx Pharmaceuticals, Inc. +6.70% -41.78%
May. 15 Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection CI
May. 15 Transcript : Acurx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 15, 2024

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ACURX PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
-0.89%+6.70%-41.78%-26.40% - 35.29M
Bullish
Bearish
Neutral
  1. Stock Market
  2. Equities
  3. ACXP Stock
  4. Charts Acurx Pharmaceuticals, Inc.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW